Collegium Pharmaceutical Investor Relations Material

Collegium Pharmaceutical, Inc., is a specialty pharmaceutical company that develops and commercializes medicines for pain management. Collegium's product portfolio includes proprietary synthetic morphine formulations, proprietary oral immediate-release hydrocodone combination medication, branded Vicoprofen TFS, and branded C-III controlled and extended-release hydrocodone combination medications. The company is committed to advancing non-opioid solutions for the treatment of moderate to severe chronic pain, including cancer, through their portfolio of therapies.